WinstonWınston
SheerVision logo

SheerVision

SVSO
28
Medical - Instruments & Supplies · Healthcare
Winston Score
28
Winston is worried
Below-average fundamentals — multiple weak pillars.

SheerVision, Inc. makes specialized loupes and lighting systems used by surgeons, dentists, and other medical professionals. Loupes are small magnifying lenses worn like glasses that help clinicians see fine details during procedures. The company sells directly to healthcare practitioners and operates in the niche medical optics segment of the broader medical instruments industry.

SheerVision earns revenue primarily through direct product sales of its optical and illumination equipment, with no significant subscription component. The company is small, with a market cap near zero, and competes against larger, better-funded optics manufacturers. Its 62% gross margin suggests decent pricing power on its products, but a deeply negative return on invested capital signals the business is not yet generating efficient returns. The main risk is its very small size, which limits its ability to invest in sales, distribution, and product development against larger rivals.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+13.0% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+712.2% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

72.4%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$0 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

SheerVision has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
67.3%
Premium pricing power — 67.3% gross margin
Operating Margin
1.4%
Thin — 1.4% operating margin
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-19.9%
Shrinking sales (-19.9% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-2.2%
Burning cash (-2.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
44.52x
Comfortably covers interest (44.5x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial